Institute for Medical Education and Research, Madelyn Trupkin Herzfeld, IMER, imer, imier, Miami, Florida, Nursing CE's, Nursing contact hours, nursing education, continuing education, medical research and education, Oncology, Postgraduate credit, oncology nurses, nurses, symposia, symposium, online educational credit, Breast Cancer, Cancer, cancer, breast cancer, colorectal cancer, Colorectal Cancer, Targeting EGFR, EGFR Inhibitors, egfr inhibitors, head and neck cancer, Anti-VEGF, VEGF Inhibitors, vegf inhibitors, lung cancer, head cancer, CINV, cinv, Chemotherapy Induced Nausea & Vomiting, chemotherapy, nausea, vomiting, mucositis, cancer pain, chronic pain  
IMER Oncology Nurse Regional Tour
   
  CE REGIONAL MEETINGS FOR ONCOLOGY NURSES

IMER Regional Meeting

Roundtable Case Discussions on Lung Cancer Symptom Management

Sponsored by:

IMER

 

Target Audience

This activity has been designed to meet the educational needs of patient care oncology nurses.

Purpose

To educate oncology nurses on the most recent treatment strategies for the management of patients with lung cancer.

Program Overview

The treatment paradigm of non-small cell lung cancer (NSCLC) has shifted in recent years. The inclusion of novel chemotherapeutic agents and targeted therapies into the multimodality approach has resulted in improved patient outcomes. However, the severity and duration of side effects associated with these agents can affect quality of life as well as efficacy of treatment. It is often necessary to adjust treatment schedules, sequences, doses, and number of cycles to alleviate adverse events. Oncology nurses and advanced practice oncology nurses play a critical role in ensuring the optimal delivery of these agents. During this interactive, educational roundtable discussion, a lung cancer oncology nurse key opinion leader will review current treatment options for NSCLC. Our expert faculty will discuss common treatment experiences, and effective nursing management strategies to ensure optimal patient outcomes. The remainder of the program will focus on case-based presentations highlighting the clinical course of patients with NSCLC who have been treated with a variety of therapeutic regimens. These case studies will allow the audience to explore the journey from diagnosis through treatment, including side-effect onset and resolution. The discussion will provide an explanation of the rationale behind the selection of each specific treatment approach for these patients. The goal is to assist oncology nurse attendees in their critical evaluation of individualized treatment planning based on a patient’s risk profile, disease presentation, and lifestyle. Following the case studies, each table of participants will collaborate to address a list of questions related to the management of the case, with one nurse from each table sharing the critical analysis. Faculty will provide expert feedback to these interactive sessions.

Learning Objectives

Upon completion of this program, participants should be better able to:

  • Describe current treatment for patients with NSCLC
  • Discuss latest clinical research developments in NSCLC
  • Describe administration guidelines for therapies used in the treatment of NSCLC
  • Discuss management strategies for common toxicities associated with NSCLC therapies
  • List appropriate patient education tools for patients receiving NSCLC therapies
  • Discuss appropriate treatment strategies for the older patient with NSCLC

Chairperson

Elizabeth S. Waxman, RN, MSN, AOCN®
University of Texas M. D. Anderson Cancer Center

 

 

 

 

There is no fee for this educational activity.

This activity is supported by independent educational grants from Genentech BioOncology, OSI Oncology, and sanofi-aventis U.S.
 

Additional CE Meetings on This Topic:

Click on the column headers to sort and on a city for more details.
{date} {city} {speaker}

{icon}
{location}

More meetings to be added in the near future. Check for updates.

Program Agenda

Program Overview 5 minutes
NSCLC: Current Treatment and Clinical Research Update

15 minutes
Oncology Nursing Focused NSCLC Case Presentations 40 minutes
Clinical Management: Case Presentation 20 minutes
Treatment Considerations for the Older Adult 10 minutes
Future Directions in Lung Cancer Treatment 10 minutes
Questions & Answers 10 minutes

 

Disclosure of Conflicts of Interest

The Institute for Medical Education & Research (IMER) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by IMER for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accreditation Statements

This educational activity for up to 1.5 contact hours will be provided by IMER. IMER is an approved provider of continuing education by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

A statement of credit will be issued only upon receipt of a completed activity evaluation form.